ClinicaliQ Trial Snapshot
- A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants — Recruiting • Rheumatology • NCT07175285.
- Trial comparing treatment options for lupus patients not responding adequately to current standard steroids and immunosuppressive drugs.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The purpose of this study is to characterize the efficacy and safety of current standard of care treatment options in participants with active systemic lupus erythematosus (SLE; including lupus nephritis) with inadequate response to glucocorticoids and at least two immunosuppressants Conditions: Systemic Lupus Erythematosus (SLE) Interventions: Current standard of care treatment options Lead Sponsor: Bristol-Myers Squibb Planned Enrollment: 223 participants